TY - JOUR
T1 - Facial analysis technology for the detection of Down syndrome in the Democratic Republic of the Congo
AU - Porras, Antonio R.
AU - Bramble, Matthew S.
AU - Mosema Be Amoti, Kizito
AU - Spencer, D'Andre A.
AU - Dakande, Cécile
AU - Manya, Hans
AU - Vashist, Neerja
AU - Likuba, Esther
AU - Ebwel, Joachim Mukau
AU - Musasa, Céleste
AU - Malherbe, Helen
AU - Mohammed, Bilal
AU - Tor-Diez, Carlos
AU - Ngoyi, Dieudonné Mumba
AU - Katumbay, Désiré Tshala
AU - Linguraru, Marius George
AU - Vilain, Eric
N1 - Funding Information:
This work was partially supported by the National Center for Advancing Translational Sciences under grant UL1 TR001876/KL2 TR001877 . This work was also supported by the A. James Clark Distinguished Professor of Molecular Genetics Endowment to Professor Eric Vilain, MD, PhD, A. James Clark Professor, Children's National Hospital . M. S. B. was supported by the Fogarty International Center of the National Institutes of Health (NIH) under Award Number D43TW009343 and the University of California Global Health Institute (UCGHI) ; The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or UCGHI.
Publisher Copyright:
© 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Down syndrome is one of the most common chromosomal anomalies affecting the world's population, with an estimated frequency of 1 in 700 live births. Despite its relatively high prevalence, diagnostic rates based on clinical features have remained under 70% for most of the developed world and even lower in countries with limited resources. While genetic and cytogenetic confirmation greatly increases the diagnostic rate, such resources are often non-existent in many low- and middle-income countries, particularly in Sub-Saharan Africa. To address the needs of countries with limited resources, the implementation of mobile, user-friendly and affordable technologies that aid in diagnosis would greatly increase the odds of success for a child born with a genetic condition. Given that the Democratic Republic of the Congo is estimated to have one of the highest rates of birth defects in the world, our team sought to determine if smartphone-based facial analysis technology could accurately detect Down syndrome in individuals of Congolese descent. Prior to technology training, we confirmed the presence of trisomy 21 using low-cost genomic applications that do not need advanced expertise to utilize and are available in many low-resourced countries. Our software technology trained on 132 Congolese subjects had a significantly improved performance (91.67% accuracy, 95.45% sensitivity, 87.88% specificity) when compared to previous technology trained on individuals who are not of Congolese origin (p < 5%). In addition, we provide the list of most discriminative facial features of Down syndrome and their ranges in the Congolese population. Collectively, our technology provides low-cost and accurate diagnosis of Down syndrome in the local population.
AB - Down syndrome is one of the most common chromosomal anomalies affecting the world's population, with an estimated frequency of 1 in 700 live births. Despite its relatively high prevalence, diagnostic rates based on clinical features have remained under 70% for most of the developed world and even lower in countries with limited resources. While genetic and cytogenetic confirmation greatly increases the diagnostic rate, such resources are often non-existent in many low- and middle-income countries, particularly in Sub-Saharan Africa. To address the needs of countries with limited resources, the implementation of mobile, user-friendly and affordable technologies that aid in diagnosis would greatly increase the odds of success for a child born with a genetic condition. Given that the Democratic Republic of the Congo is estimated to have one of the highest rates of birth defects in the world, our team sought to determine if smartphone-based facial analysis technology could accurately detect Down syndrome in individuals of Congolese descent. Prior to technology training, we confirmed the presence of trisomy 21 using low-cost genomic applications that do not need advanced expertise to utilize and are available in many low-resourced countries. Our software technology trained on 132 Congolese subjects had a significantly improved performance (91.67% accuracy, 95.45% sensitivity, 87.88% specificity) when compared to previous technology trained on individuals who are not of Congolese origin (p < 5%). In addition, we provide the list of most discriminative facial features of Down syndrome and their ranges in the Congolese population. Collectively, our technology provides low-cost and accurate diagnosis of Down syndrome in the local population.
KW - Congo
KW - DRC
KW - Down syndrome
KW - Facial analysis
KW - Machine learning
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85108693929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108693929&partnerID=8YFLogxK
U2 - 10.1016/j.ejmg.2021.104267
DO - 10.1016/j.ejmg.2021.104267
M3 - Article
C2 - 34161860
AN - SCOPUS:85108693929
SN - 1769-7212
VL - 64
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 9
M1 - 104267
ER -